By Alex Liu | Posted February 24, 2010
"The Food and Drug Administration has approved the use of psilocybin, the active ingredient of psychedelic mushrooms, in pilot clinical trials to treat end-of-life distress. [Credit: Rohan523, wikimedia.org]"
Sphere: Related Content
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment